Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucel.Published in:Leukemia & Lymphoma, 2022, v. 63, n. 14, p. 3385, doi. 10.1080/10428194.2022.2123232By:Fried, Shalev;Shouval, Roni;Varda-Bloom, Nira;Besser, Michal J.;Yerushalmi, Ronit;Shem-Tov, Noga;Danylesko, Ivetta;Jacoby, Elad;Teihman, Shlomit;Itzhaki, Orit;Fein, Joshua A.;Kedmi, Meirav;Shimoni, Avichai;Nagler, Arnon;Avigdor, AbrahamPublication type:Article